NEW STUDY. People who have been vaccinated against COVID-19 have a significantly lower risk of being diagnosed with Post-COVID Condition after COVID-19 infection, according to a study at the University of Gothenburg. The researchers emphasize the importance of vaccination to reduce human suffering and pressure on healthcare services. The study, published in the journal BMJ, includes all registered cases among adults who contracted COVID-19 for the first time between December 27,…
Hardly any photos of patients with psoriasis in published studies
NEW STUDY. Very few patients with psoriasis are depicted in scientific articles – only a fraction of those included in the research are represented in images. This is revealed by a study from the University of Gothenburg, Sweden together with researchers from the University of Copenhagen, Denmark. The lack of images complicates communication with patients, according to the researchers. For this systematic review article, the researchers counted images of patients…
Some increase in cancer after 1986 Chernobyl disaster
NEW STUDY. The nuclear accident in Chernobyl in 1986 led to the spread of radioactivity across Sweden and Europe. In a long-term study researchers have used new, more specific calculation methods to show the connection between radiation dose and certain types of cancer. The study, published in the journal Environmental Epidemiology, is based on a collaboration between Uppsala University, Uppsala University Hospital, Lund University and University of Gothenburg. One of the authors is…
Higher risk of 17 cancers after high BMI in late teens
NEW STUDY. Men who are overweight or obese at age 18 have a higher risk of 17 different cancers later in life. This has been shown in a study at the University of Gothenburg. The research also describes how the youth obesity epidemic is expected to affect the cancer situation over the next 30 years. In August, a study on higher cancer risk in men who had lower aerobic fitness…
Groundbreaking study changes the treatment of lung transplant patients
NEW STUDY. After ten years of research, it is now clear which medication is most effective in preventing both acute and chronic rejection after lung transplantation. The treatment algorithm throughout Scandinavia has been changed thanks to a multinational study led by Göran Dellgren at the University of Gothenburg. The study was recently published in The Lancet Respiratory Medicine. The study, named ScanCLAD, compared the effectiveness of the two traditionally used…